TGF‐β exhibits a dual role in HCC by acting tumor‐suppressive at early stages and tumor‐promoting at later stages.22 Using long‐term TGF‐β‐treated HCC cell models, we aimed at elucidating the molecular mechanisms of the “TGF‐β switch” to better understand HCC progression. This evidence concerns the gene TGFB1 and neoplasm.